Foxo Technologies Faces Delisting on NYSE | Twin Cities Business
Shares of Minneapolis-based biotech startup Foxo Technologies had been trading on the exchange for less than a year.
Source: tcbmag.com
Stay updated with breaking news from Jon Sabes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Minneapolis-based biotech startup Foxo Technologies had been trading on the exchange for less than a year.
After a red-hot 2020 and 2021, only two companies went public last year.
The Securities and Exchange commission is seeking documents related to the November firing of Foxo Technologies' CEO.
The board terminated Jon Sabes and his brother the same day the company delayed its quarterly financial report.
The biotech company is the first Minnesota company to go public this year.